Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Livanova Plc OR Sh (NQ: LIVN )

51.08 -0.62 (-1.20%)
Streaming Delayed Price Updated: 3:14 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 245,081
Open 51.65
Bid (Size) 51.03 (7)
Ask (Size) 51.18 (7)
Prev. Close 51.70
Today's Range 50.55 - 51.87
52wk Range 42.75 - 64.47
Shares Outstanding 49,023,767
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
From LivaNova PLC
Via Business Wire
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints
From LivaNova PLC
Via Business Wire

Performance

YTD
+1.07%
+1.07%
1 Month
-4.22%
-4.22%
3 Month
+10.95%
+10.95%
6 Month
-13.98%
-13.98%
1 Year
+15.96%
+15.96%

More News

Read More
LivaNova Reports Third-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
LivaNova Appoints Susan Podlogar as a New Director
From LivaNova PLC
Via Business Wire
LivaNova's New Strategy Could Unlock Revenue, Profit Gains, Analyst Predicts
Via Benzinga
LivaNova to Announce Third-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
LivaNova to Present at the Baird Global Healthcare Conference
From LivaNova PLC
Via Business Wire
LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
LivaNova Reports Second-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Goldman Sachs Healthcare Conference
From LivaNova PLC
Via Business Wire
LIVN Stock Earnings: LivaNova Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
LivaNova Reports First-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
From LivaNova PLC
Via Business Wire
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
From LivaNova PLC
Via Business Wire
LivaNova to Announce First-Quarter 2024 Results
From LivaNova PLC
Via Business Wire
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
From LivaNova PLC
Via Business Wire
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
From LivaNova PLC
Via Business Wire
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
From LivaNova
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.